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Acne vulgaris is the most common disease of the pilosebaceous unit. The pathogenesis of this inflammatory
disease is complex, involving increased sebum production and perifollicular inflammation. To identify effective
agents for factors that induce acne vulgaris, we explored the pharmacological potential of epigallocatechin-3-
gallate (EGCG), which has been widely investigated as an anti-proliferative and anti-inflammatory agent. In this
study, we demonstrated that topical application of EGCG to rabbit auricles reduced the size of the sebaceous
glands. When applied to cultured human SZ95 sebocytes, EGCG strongly suppressed cell proliferation and
lipogenesis. These actions of EGCG were reproduced in IGF-I-differentiated SZ95 sebocytes. To investigate the
anti-inflammatory potential of EGCG, we evaluated pro-inflammatory cytokine synthesis in IGF-I-differentiated
SZ95 sebocytes and found that expression of IL-1, IL-6, and IL-8 was decreased. These results provide early
evidence that EGCG is an effective candidate for acne therapy whose mechanisms of action in IGF-I-
differentiated SZ95 sebocytes include the inhibition of lipogenesis and inflammation.
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INTRODUCTION
Acne is a complex, chronic, and common skin disorder
of the pilosebaceous unit. Excessive sebum production has
important roles in formation of the primary lesions associated
with acne, in addition to the hyperkeratinization of
pilosebaceous ducts, hyperproliferation of Propionibacterium
acnes, and production of perifollicular inflammation
(Zouboulis, 2005).
A growing body of evidence underlines the role of
increased IGF-I signaling in the pathogenesis of acne. The
peak incidence of acne occurs during adolescence, when
serum IGF-I levels reach their peak (during the growth spurt)
(Deplewski and Rosenfield, 1999), and IGF-I levels showed a
positive correlation with the severity of acne in women with
clinical acne (Cappel et al., 2005). Milk consumption and
hyperglycemic diets can induce IGF-I production, thereby
causing sebaceous lipogenesis and sebocyte proliferation,
which can aggravate acne (Makrantonaki et al., 2008; Melnik
and Schmitz, 2009). Therefore, pharmacological downregu-
lation of IGF-I might be a promising new strategy in the
treatment of acne vulgaris.
Epigallocatechin-3-gallate (EGCG) is the main polypheno-
lic fraction of green tea. It has various bioactivities, including
anti-oxidative, anti-inflammatory, anti-bacterial, anti-obesity,
and anti-mutagenic effects (Cabrera et al., 2006). Addition-
ally, it inhibits proliferation of various cells, probably by
blocking IGF/IGF-IR-related autocrine or paracrine loops
(Shimizu et al., 2008; Kang et al., 2010). Some investigators
have reported that EGCG has clinical efficacy as an acne
therapeutic agent (Elsaie et al., 2009; Mahmood et al., 2010).
However, evidence is lacking regarding the pharmacologic
mechanism of action of EGCG in the treatment of acne, and
its potential efficacy also needs to be clarified.
In this study, we examined the effects of EGCG on IGF-I-
induced lipogenesis and inflammation in human sebocytes.
Our data provide compelling evidence that EGCG has potent
anti-IGF-I effects, not only by inhibiting lipogenesis and cell
proliferation but also by suppressing inflammatory cytokine
expression. Hence, it is tempting to propose that EGCG could
be an interesting candidate for the treatment of acne vulgaris.
RESULTS
EGCG reduces the sizes of comedones and sebaceous glands on
rabbit ears
We first examined the effects of EGCG on sebaceous glands
in rabbits by comparing its effects with those produced by
all-trans-retinoic acid, a well-known anti-comedonic agent.
When auricles were treated with 2% EGCG or 0.2% all-
trans-retinoic acid, comedo size was reduced compared with
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that in rabbits treated with vehicle alone (Figure 1a–c and g).
To evaluate morphologic changes in sebaceous glands, we
examined the relative sizes of sebaceous glands and sebocyte
counts per gland in each group. Although sebaceous glands
in control rabbits were characteristically large and multi-
lobular, those in rabbits that received EGCG showed
reductions in size and in the mean numbers of sebocytes
per gland, as did those in rabbits treated with all-trans-
retinoic acid (Figure 1d–f, h and i).
EGCG inhibits cell proliferation and lipid synthesis in SZ95
sebocytes
To explore the potential of EGCG in vitro, we used human
SZ95 sebocytes. The effects of various doses of EGCG on the
proliferation of cultured SZ95 sebocytes were determined.
EGCG reduced the growth rate of SZ95 sebocytes at doses
of 25–100mM (Figure 2a). We also assessed the proliferation
of SZ95 sebocytes by [3H]-thymidine uptake assay, and the
results clearly indicated that, similar to 13-cis retinoic acid,
EGCG reduced the proliferation of SZ95 sebocytes in a dose-
dependent manner (Figure 2b). To investigate the role of
EGCG in lipid synthesis in sebocytes, we examined
intracellular lipid droplet formation by Oil Red O staining.
When SZ95 sebocytes were treated with various doses of
EGCG, a reduction in lipid accumulation in the cytoplasm
was detected by microscopy (Figure 2c). The decrease in
intracellular lipid levels was further quantified by measuring
optical densities after Oil Red O staining. As shown in Figure
2d, EGCG treatment, similar to 13-cis retinoic acid treatment,
caused a dose-dependent reduction in intracellular lipid
levels per cell.
EGCG inhibits cell proliferation in IGF-I-treated SZ95 sebocytes
by affecting apoptosis
To clarify the anti-acne actions of EGCG, we examined
its effects on cell proliferation and lipid synthesis in
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Figure 1. Effects of topically applied epigallocatechin-3-gallate (EGCG) on rabbit sebaceous glands. Different groups of 10 rabbit auricles were treated with 2%
EGCG (b, e), 0.2% all-trans-retinoic acid (atRA) (c, f) in 70% propylene glycol/30% ethanol, or vehicle (a, d) for 14 days. After treatments, comedone size was
evaluated by digital image analysis (g). Auricle tissues were stained with hematoxylin–eosin, and sebaceous gland size (h) and sebocyte count (i) were then
determined in 30 consecutive sebaceous glands. Cont, vehicle-treated controls. Bars¼50 mm (a–c) and 100mm (d–f). Data represent the mean mean±SE (n¼ 5).
Data were analyzed by Student’s t-test (*Po0.05, **Po0.01, ***Po0.001).
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IGF-I-differentiated SZ95 sebocytes. In this study, EGCG
inhibited IGF-I-induced proliferation in SZ95 sebocytes in a
dose-dependent manner (Figure 3a). To test the hypothe-
sis that EGCG induces apoptosis, we examined the
effects of EGCG on IGF-I-treated SZ95 sebocytes in annexin
V-FITC experiments. EGCG was found to increase the
apoptotic cell population, which was reduced by IGF-I
(Figure 3b). To confirm the apoptotic effects of EGCG, we
investigated selective cleavage of the nuclear enzyme
poly(ADP ribose) polymerase by caspase 3. Cleaved caspase
3 and poly(ADP ribose) polymerase were not or were
weakly detected in negative control lanes and in cells treated
with IGF-I alone. In EGCG-treated SZ95 sebocytes, levels
of the proactive and cleaved forms of caspase 3 and
poly(ADP ribose) polymerase were significantly increased
(Figure 3c). These results suggest that the reduced prolifera-
tion of EGCG-treated SZ95 sebocytes is due to the induction
of apoptosis.
EGCG inhibits lipid synthesis in IGF-I-treated SZ95 sebocytes
via Akt/mTOR signaling
Similar to the results for cell proliferation, EGCG dose-
dependently reduced lipid levels in IGF-I-treated SZ95
sebocytes (Figure 4a). This result prompted us to examine
the molecular mechanism by which EGCG suppresses lipid
synthesis. First, we examined whether EGCG inhibits activa-
tion of IGF-IR under the stimulation of IGF-I in SZ95 sebocytes
(Figure 4b). We found that exogenous IGF-I increased the
levels of phosphorylated IGF-IR, and treatment with EGCG
markedly decreased the levels of the phosphorlated IGF-IR
protein. To provide additional evidence that EGCG targets
IGF-IR signaling, we next examined whether EGCG inhibits
other known downstream effector pathways of IGF-IR
(Figure 4c). Previous studies have reported that IGF-I transmits
its lipogenic signal in sebocytes via acutely transforming
retrovirus Akt8 in rodent T-cell lymphoma (Akt) pathway
(Smith et al., 2008). Levels of phosphorylated Akt were, as
expected, increased by IGF-I. There was a remarkable change
in phosphorylated Akt levels following EGCG treatment. We
further attempted to identify Akt pathway intermediates that
are regulated by EGCG. We found that phosphorylated
mammalian target of rapamycin (mTOR) and S6 ribosomal
protein, critical downstream elements in the Akt pathway,
were regulated by EGCG with dose-dependent decreases.
Furthermore, levels of peroxisome proliferator-activated
receptor-g, a potential modulator of lipid production in
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Figure 2. Inhibition of cell proliferation and lipid synthesis by epigallocatechin-3-gallate (EGCG) in SZ95 sebocytes. (a) The dose-dependent effect of EGCG
on SZ95 sebocyte proliferation was determined by crystal violet staining. (b) Rate of [3H]-thymidine incorporation in SZ95 sebocytes treated with various
doses of EGCG or 13-cis retinoic acid (13cisRA), calculated as percentage of the value in untreated cells. (c) Detection of intracellular lipids in SZ95
sebocytes treated with EGCG by microscopy after Oil red O staining. Bars¼ 20mm. (d) Lipid levels in SZ95 sebocytes treated with various doses of EGCG
or 13cisRA, calculated as percentage of the value in untreated cells. Data represent the mean±SE (n¼ 5). Data were analyzed by Student’s t-test (*Po0.05,
**Po0.01, ***Po0.001).
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human sebocytes (Alestas et al., 2006; Trivedi et al., 2006)
were also significantly reduced by EGCG. These results
suggest that EGCG suppresses Akt/mTOR signaling and that
this suppression may correlate with inhibition of IGF-I-
induced lipogenesis in sebocytes.
EGCG regulates inflammatory cytokine production in IGF-I-
treated SZ95 sebocytes
To investigate the anti-inflammatory effects of EGCG in acne,
we first analyzed a panel of inflammatory cytokines that are
detectable by multi-protein blotting (Figure 5a). Treatment
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Figure 3. Inhibition of cell proliferation by epigallocatechin-3-gallate (EGCG) in IGF-I-treated SZ95 sebocytes. (a) SZ95 sebocytes were treated for 6 days
with various doses of EGCG in the presence of 20 ngml–1 IGF-I. Rate of [3H]-thymidine incorporation in SZ95 sebocytes calculated as percentage of the
value in untreated cells. None, untreated control cells. (b) Representative flow cytometry dot plots for SZ95 sebocytes stained with annexin V/propidium
iodide (PI) after treatment for 48 hours with 50mM EGCG in the presence of 20 ngml–1 IGF-I. Apoptotic cell numbers are shown as percentages in the annexin
V-positive dot-plot quadrants. (c) Analysis of levels of active caspase 3 and cleaved poly(ADP ribose) polymerase (PARP) fragments in SZ95 sebocytes by western
blotting. Data represent the mean±SE (n¼ 6). *Po0.05 versus untreated cells; wPo0.05 versus IGF-I-treated cells.
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Figure 4. Inhibition of lipid synthesis by epigallocatechin-3-gallate (EGCG) in IGF-I-treated SZ95 sebocytes. (a) SZ95 sebocytes were treated with 20 ngml–1
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with 20 ngml–1 IGF-I upregulated the inflammatory cytokines
growth regulated oncogene, growth regulated oncogene-a,
IL-1a, IL-6, and IL-8. Production of these cytokines by IGF-I-
treated cells was downregulated by 50mM EGCG (Figure 5b).
Three of these proinflammatory cytokines, IL-1a, IL-6, and IL-
8, were already known to be upregulated in acne lesions
(Alestas et al., 2006; Kurokawa et al., 2009). We detected
significant differences in two of them (IL-1a and IL-6) by
densitometry (Figure 5c).
To confirm these results, we investigated intracellular
expression of IL-1a and IL-6 by immunofluorescence analysis
of SZ95 sebocytes. As shown in Figure 6a, IL-1a and IL-6
immunoreactivity was increased after treatment of cultured
sebocytes with 20 ngml–1 IGF-I. Co-treatment with IGF-I and
EGCG (50 mM) reduced IL-1a and IL-6 immunoreactivity in
SZ95 sebocytes compared with cells exposed to IGF-I alone.
The suppressive effect of EGCG on IL-1a and IL-6 protein
levels was subsequently confirmed at the mRNA expression
level by reverse transcription–PCR (Figure 6b and c).
DISCUSSION
Flavonoids from medicinal plants exert various pharmacolo-
gical effects and as a result, they have been studied
extensively as potential treatments for various types of
diseases (Robak and Gryglewski, 1988; Kawaii et al., 1999).
A growing volume of basic science literature supports the role
of flavonoids in acne therapy. Nobiletin, which is found in
the juice of Citrus depressa Hayata, has been shown to inhibit
sebum production and sebocyte proliferation and to augment
sebum excretion in hamsters (Sato et al., 2007). Kaempferol
and quercetin, found in Impatiens balsamina flowers, have
been shown to possess anti-bacterial activities against
Propionibacterium acnes, a contributing factor in acne (Lim
et al., 2007). EGCG is a pro-active ingredient of green tea,
whereas 3% green tea emulsion reduces sebum production in
healthy skin (Mahmood et al., 2010), and 2% green tea lotion
was shown effective in mild-to-moderate acne (Elsaie et al.,
2009). However, it remains controversial whether EGCG has
actually an effect on acne because there is no evidence
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Figure 5. Inflammatory cytokine profiles in SZ95 sebocytes. (a) The RayBio Human Cytokine Antibody Array. A total of 23 antibodies against cytokines were
included in the array. Neg, negative control; Pos, positive control. (b) Treatment with 20 ngml–1 IGF-I resulted in upregulation of five inflammatory cytokines
(identified by empty squares). Treatment with 50mM EGCG resulted in downregulation of these cytokines. (c) Densitometry analysis of these cytokine signals.
Cytokine signals were normalized to those for positive antibody array controls. Data represent the mean±SE (n¼3). *Po0.05, **Po0.01 versus untreated
control cells; wPo0.05, zPo0.01 versus IGF-I-treated cells. GRO, growth regulated oncogene.
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regarding the pharmacological mechanism of its action.
Here, we further explored the pharmacological potential of
EGCG on rabbit ears and a relevant in vitro sebocyte system,
the SZ95 sebaceous gland cell line (Zouboulis et al., 1999).
We have hypothesized that inhibitors of IGF-I signaling
could be a new class of therapeutic agents for acne and
therefore examined whether EGCG suppresses IGF-I-aug-
mented proliferation and lipogenesis in SZ95 sebocytes. The
results of this study were consistent with previous studies
showing that IGF-I increases proliferation by protecting cells
from apoptosis (Deplewski and Rosenfield, 1999; Allen et al.,
2005; Douglas et al., 2007). EGCG suppressed the prolifera-
tion of IGF-I-treated SZ95 sebocytes by inducing apoptosis,
which suggests that EGCG may interfere with IGF-I-induced
sebaceous gland enlargement. We also showed that IGF-I
increased lipid synthesis in SZ95 sebocytes, however, when
cells were treated with EGCG, IGF-I failed to induce
lipogenesis. To better elucidate the signaling pathway by
which EGCG inhibits lipid production in SZ95 sebocytes, we
identified IGF-IR and its multiple downstream signaling
pathways that are regulated by EGCG under the stimulation
of IGF-I. In this study, we have shown that EGCG inhibits
activation of IGF-IR as well as its downstream effectors,
especially Akt, mTOR, and S6. These findings indicate that
EGCG can overcome the stimulatory effects of IGF-I, and Akt,
mTOR and S6 may be a suitable anti-IGF-I agent. In a
previous study, mTOR signaling regulated peroxisome pro-
liferator-activated receptor-g (Kim and Chen, 2004), which is
known to have major regulatory roles in the differentiation of
sebocytes and lipid production (Chen et al., 2003; Downie
et al., 2004; Trivedi et al., 2006). However, the precise
mechanism by which EGCG inhibits activation of receptor Y
kinase remains to be determined. It is also conceivable that
EGCG targets other receptor Y kinases, common downstream
components of multiple receptor Y kinases, or activates a
phosphatase negatively regulating IGF-IR (and/or other
receptor Y kinases). Nevertheless, we found that EGCG
inhibits activation of the IGF-IR and related downstream
signaling pathways in SZ95 sebocytes. In this study, we also
provide the first evidence that the suppression of Akt/mTOR
signaling by EGCG may inhibit IGF-I-augmented lipid
synthesis in sebocytes.
We next investigated the effects of EGCG on IGF-I-
induced inflammatory cytokine production in SZ95 sebo-
cytes. There is, as yet, no evidence that IGF-I directly induces
the inflammatory response in acne. However, previous
studies established that IGF-I is a regulator of in vitro cytokine
expression in the immune system. IGF-I has been shown to
stimulate tumor necrosis factor-a, IL-8, IL-6 secretion in
various human cells (Renier et al., 1996; Tu et al., 1999;
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Figure 6. Regulation of inflammatory cytokines in IGF-I-treated SZ95 sebocytes by epigallocatechin-3-gallate (EGCG). (a) SZ95 sebocytes were treated with
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Kooijman et al., 2002, 2003). Based on this evidence, we
investigated whether IGF-I stimulates inflammatory cytokine
production and found that IGF-I increased the production of
several inflammatory cytokines. EGCG has been shown to
have anti-inflammatory effects in various cell types (Wheeler
et al., 2004; Kim et al., 2006; Zheng et al., 2010). Our
findings provide evidence that EGCG has a significant
suppressive effect on IGF-I-induced IL-1a and IL-6 expression
in SZ95 sebocytes. IL-1a and IL-6 are the major acne lesion-
associated cytokines (Ingham et al., 1992; Alestas et al.,
2006). This finding suggests that EGCG may, as well as
antagonizing IGF-I, inhibit inflammation by additional
mechanisms. Hence, it is tempting to propose that EGCG
may be a reasonable candidate for the treatment of
inflammatory acne lesions, although its exact mechanism of
action remains to be clarified.
Two additional properties of EGCG have been linked to
the pathogenesis of acne. The earliest pathological change in
acne is altered follicular epithelial proliferation, resulting in
follicular retention hyperkeratosis and microcomedones.
Our results showed the inhibitory effect of EGCG on IGF-1-
induced proliferation of keratinocytes (Supplementary Figure
S1 online). In several studies, EGCG induced differential
effects between tumor and normal cells. EGCG exhibited a
pronounced growth inhibitory effect on tumor cells, but not
on normal ones (Chung et al., 2003; Hsu et al., 2003). Our
data suggest that EGCG may be a good candidate to suppress
the proliferation of keratinocytes in IGF-1-induced hyperpro-
liferative conditions, such as acne. The other property of
EGCG linked to the pathogenesis of acne is its anti-microbial
effect. EGCG has been shown to have anti-microbial activity
against a variety of organisms, including Gram-positive,
Gram-negative, and fungal pathogens (Yoda et al., 2004; Park
et al., 2006; Osterburg et al., 2009). We confirmed that
Propionibacterium acnes, which has a critical role in the
development of inflammatory acne, is also susceptible to
EGCG (Supplementary Figure S2 online).
Despite our considerations of the potential anti-acne role
of EGCG, there remain several major challenges in interpret-
ing the clinical relevance of our data. The results of several
current studies elucidating the pharmacology and pharma-
cokinetics of EGCG in humans (Mahmood et al., 2010;
Williamson et al., 2011) support further studies for optimal
topical EGCG formulation and clinical application in acne
patients. In conclusion, we have demonstrated that EGCG
suppresses IGF-I-induced sebocyte proliferation, lipogenesis,
and cytokine expression. Taken together with our supple-
mentary data, this preliminary evidence suggests that EGCG
could be an interesting candidate for the treatment of IGF-I
aggravated acne.
MATERIALS AND METHODS
Animal study
Female New Zealand white rabbits (Daehan BioLink, Eumseong,
Korea) were used in an animal experiment. The experiment was
approved by Chungnam National University’s Institutional Animal
Care and Use Committees and was conducted in accordance with
the guidelines for the Care and Use of Laboratory Animals. The
rabbits’ auricles were topically treated twice a day for 14 days with
2% EGCG (Sigma, St Louis, MO) or 0.2% all-trans-retinoic acid
(Sigma) in 70% propylene glycol/30% ethanol, or with the same
volume of vehicle. After treatment, the overall area covered with
comedones relative to the overall area covered by follicular orifices
was calculated by digital image analysis, performed using a
phototrichogram system (Folliscope, Lead-M, Seoul, Korea).
Histochemical analysis
Tissue samples from three adjacent sites per auricle were obtained
by 6-mm punch biopsy under local anesthesia, fixed with 10%
formaldehyde, embedded in paraffin, and sectioned. Tissue sections
were subjected to hematoxylin–eosin staining, and all stained tissue
sections were then subjected to image analysis of sebaceous gland
sizes. One to five sebaceous glands were identified in each
specimen, and the sum of their areas was taken to comprise the
total area. Images were captured and measurements were obtained
using IMT i-solution software (IMT i-solution, Vancouver, BC,
Canada). For a given slide, we also counted sebocytes in the glands
at their largest diameters because a vertical section through the
central portion of a gland would be proportional to the overall size of
the gland, whereas peripheral sections would lead to underestima-
tion of the true gland size.
Cell culture
Immortalized SZ95 human sebocytes (Zouboulis et al., 1999)
showing morphologic, phenotypic, and functional characteristics
of normal human sebocytes were cultured in Sebomed medium
(Biochrom, Berlin, Germany) supplemented with 10% fetal bovine
serum (Gibco BRL, Rockville, MD) and 5ngml–1 recombinant
human epidermal growth factor (Invitrogen, Grand Island, NY).
Cell growth analysis
Cell growth curve was generated by crystal violet staining. Cells
were seeded with low cell density in triplicates and allowed to grow
for 6 days. In each day, cells were washed with phosphate-buffered
saline (PBS), fixed with 10% formalin and stained with 0.01% crystal
violet. Crystal violet from stained cells was extracted using 10%
acetic acid and quantified spectrophotometrically (590 nm) to
determine relative cell growth rates. We also performed a [3H]-
thymidine uptake assay. SZ95 sebocytes in 12-well culture plates
were treated every 2 days with various doses of EGCG for a total of
6 days. Cells were incubated with fresh medium containing 1 mCi
of [3H]-thymidine (Amersham, Buckinghamshire, UK). Following
incubation for the indicated periods of time, cells were washed
twice with PBS and incubated with 0.1 N NaOH at room
temperature. Levels of radioactivity in cell lysates were measured
using a liquid scintillation counter and recorded as a measure of cell
proliferation.
Oil Red O staining
SZ95 sebocytes were seeded on 12-well culture plates, incubated
overnight, and then treated with various doses of EGCG for 48 hours.
Cells treated with vehicle served as a control. At the end of the
treatment period, cells were washed with PBS and fixed through
incubation in 10% formaldehyde for 5 minutes. Fixed cells were
stained for 10 minutes with filtered Oil Red O working solution,
prepared immediately before use by making a 6:4 mixture of stock
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(0.5% Oil Red O (Sigma) in 99% isopropanol) and dH2O. Stained
cells were washed in dH2O, counterstained with hematoxylin, and
visualized by microscopy.
Lipid detection
For quantitative detection of intracellular lipids, all water was
removed from Oil Red O-stained cells, and Oil Red O was then
eluted by incubating the cells with 100% isopropanol for 10
minutes. After pipetting several times to ensure that all Oil Red O
had been eluted, supernatant Oil Red O levels were measured by
measuring the optical density at 500 nm. To calculate the amount of
lipid per cell, the optical density value was normalized to the cell
count, determined using a FACSCantoTMII flow cytometer and
FACSDiva software (BD Biosciences, San Jose, CA).
Flow cytometric analysis
To analyze apoptosis, SZ95 sebocytes were seeded into 60mm dishes,
allowed to attach overnight, and then treated with 20ngml–1 IGF-I
(Sigma) for 48 hours. Next, IGF-I-differentiated SZ95 sebocytes were
treated with 50mM EGCG in the presence of IGF-I for 48 hours. Treated
cells were washed with PBS, trypsinized with 0.05% Trypsin-EDTA
(Gibco BRL), and resuspended in binding buffer. Cells were then
stained with annexin V-FITC and propidium iodide for 20 minutes in
the dark and diluted with binding buffer to a final volume of 400ml.
Data acquisition and analysis were performed by flow cytometry.
Western blot analysis
Cells were lysed in Proprep solution (Intron, Deajeon, Korea).
Samples were run on SDS-polyacrylamide gels, transferred onto
nitrocellulose membranes, and incubated with appropriate antibo-
dies. Blots were then incubated with peroxidase-conjugated second-
ary antibodies and visualized by enhanced chemiluminescence
(Intron). The following primary antibodies were used: caspase 3,
poly(ADP ribose) polymerase, IGF-IR, phospho-IGF-IR, Akt, phos-
pho-Akt, mTOR, phospho-mTOR, phospho-S6, peroxisome prolif-
erator-activated receptor-g (Cell Signaling Technology, Danvers,
MA), and actin (Santa Cruz Biotechnologies, Santa Cruz, CA).
Cytokine array
The expression of 23 human cytokines was analyzed using a
commercially available sandwich-type assay (RayBio Human
Cytokine Antibody Array 1, RayBiotech, Atlanta, GA) that uses
membrane-bound cytokine-specific antibodies to capture cytokines
in biological fluids. SZ95 sebocytes were seeded to six-well culture
dishes and treated with 20 ngml–1 IGF-I for 48 hours and then with
50 mM EGCG for 48 hours. Analysis was performed according to the
manufacturer’s instructions. Briefly, membranes were blocked for
1 hour and then incubated with SZ95 sebocyte culture supernatant
for 2 hours. Next, the membranes were incubated with a biotin-
conjugated antibody mix for 2 hours. After consecutive washes,
streptavidin-conjugated peroxidase was added, and the membranes
were incubated for a further 2 hours. The membranes were then
washed thoroughly, exposed to chemiluminescence, and finally
exposed to autoradiographic film for 40 seconds. The film was
scanned, and spots were digitized. The pixel densities for individual
spots were calculated using IMT i-solution software. The relative
expression ratio was determined by subtraction of the background
signal and comparison with positive spots on the membrane.
Immunofluorescence
SZ95 sebocytes were grown on coverslips, fixed through incubation
with 4% paraformaldehyde for 20 minutes, and permeabilized
through incubation with 0.1%. Triton X-100 in PBS for 10 minutes at
room temperature. Cells were then incubated overnight at 4 1C with
primary antibody (anti-IL1a or anti-IL-6) (Santa Cruz Biotechnolo-
gies) and then for 1 hour at room temperature with FITC-conjugated
secondary antibody, and were finally visualized under a fluores-
cence microscope (Olympus, Tokyo, Japan).
Reverse transcription–PCR
To evaluate gene expression, total RNA was extracted using an easy-
BLUE RNA extraction kit (Intron). Two mg of total RNA was reverse
transcribed using Moloney murine leukemia virus reverse trans-
criptase (ELPIS Biotech, Daejeon, Korea). Aliquots of a reverse
transcription mixture were analyzed by PCR using specific primer
sets. The following primers were used: IL-1a, forward 50-CCCTG
TAAATTCCCCGTTTT-30 and reverse 50-AGGTGCTGACCTAGGCTT
GA-30; IL-6, forward 50-AAAGAGGCACTGGCAGAAAA-30 and reverse
50-GAGGTGCCCATGCTACATTT-30; and cyclophilin (control), for-
ward 50-CTCCTTTGAGCTGTTTGCAG-30 and reverse 50-CACCA
CATGCTTGCCATCCA-30. PCR fragments were electrophoresed on
1.0% agarose gels and subsequently visualized using ethidium
bromide. Amplification product intensity was quantified using IMT
i-solution software, and the values obtained were normalized to the
cyclophilin signals.
Statistical analysis
All experiments were repeated at least three times with different
batches of cells. Data were evaluated statistically using Student’s
t-test. Statistical significance was set at Po0.05.
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